SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,236 | -51.3% | 2,620 | -1.9% | 0.00% | – |
| Q2 2023 | $12,794 | +426366.7% | 2,671 | +352.7% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 590 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 590 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 590 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 590 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -91.8% | 590 | -90.0% | 0.00% | – |
| Q4 2021 | $49,000 | +1125.0% | 5,890 | +898.3% | 0.00% | – |
| Q3 2021 | $4,000 | -95.7% | 590 | -84.8% | 0.00% | -100.0% |
| Q2 2021 | $93,000 | +675.0% | 3,890 | +559.3% | 0.00% | – |
| Q1 2021 | $12,000 | -80.6% | 590 | -76.8% | 0.00% | – |
| Q4 2020 | $62,000 | -22.5% | 2,540 | -10.6% | 0.00% | -100.0% |
| Q3 2020 | $80,000 | +1500.0% | 2,840 | +186.9% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 990 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -94.0% | 990 | -76.4% | 0.00% | -100.0% |
| Q3 2017 | $67,000 | +34.0% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $50,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |